288 related articles for article (PubMed ID: 17954296)
1. Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease.
Aggarwal N; Batwara R; McCarthy ET; Sharma R; Sharma M; Savin VJ
Am J Kidney Dis; 2007 Nov; 50(5):826-9. PubMed ID: 17954296
[TBL] [Abstract][Full Text] [Related]
2. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
[TBL] [Abstract][Full Text] [Related]
3. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis.
Ittel TH; Clasen W; Fuhs M; Kindler J; Mihatsch MJ; Sieberth HG
Clin Nephrol; 1995 Sep; 44(3):156-62. PubMed ID: 8556831
[TBL] [Abstract][Full Text] [Related]
4. Glomerular permeability activity: prevalence and prognostic value in pediatric patients with idiopathic nephrotic syndrome.
Trachtman H; Greenbaum LA; McCarthy ET; Sharma M; Gauthier BG; Frank R; Warady B; Savin VJ
Am J Kidney Dis; 2004 Oct; 44(4):604-10. PubMed ID: 15384010
[TBL] [Abstract][Full Text] [Related]
5. Treatment of idiopathic nephrotic syndrome with cyclosporine A.
Meyrier A
J Nephrol; 1997; 10(1):14-24. PubMed ID: 9241620
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
7. [Complete remission of steroid-resistant minimal-change nephrotic syndrome by cyclosporin after additional low-density lipoprotein apheresis treatment].
Okada T; Takahashi H; Ogura M; Nakao T; Shimizu T
Nihon Jinzo Gakkai Shi; 1996 Jan; 38(1):46-51. PubMed ID: 8855137
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine in idiopathic nephrotic syndrome.
Ponticelli C
Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
Cho MH; Hong EH; Lee TH; Ko CW
Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S11-4. PubMed ID: 17995521
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the efficacy of cyclosporine A treatment in idiopathic nephrotic syndrome in children].
Wyszyńska T; Ksiazek J; Wieteska-Klimczak A; Gorzkowska-Paczwa M; Dorywalski T; Tysarowska A
Pol Merkur Lekarski; 2001 Aug; 11(62):140-3. PubMed ID: 11757213
[TBL] [Abstract][Full Text] [Related]
11. Minimal-change nephrotic syndrome preceding Hodgkin lymphoma by 5 years with expression of tumor necrosis factor alpha in Hodgkin-Reed-Sternberg cells.
Nakayama S; Yokote T; Kobayashi K; Hirata Y; Akioka T; Hiraoka N; Oka S; Miyoshi T; Takubo T; Tsuji M; Hanafusa T
Hum Pathol; 2010 Aug; 41(8):1196-9. PubMed ID: 20624522
[TBL] [Abstract][Full Text] [Related]
12. [Minimal change nephrotic syndrome complicated with recurrence of malignant thymoma: an interesting case with remission due to steroid therapy of both nephrotic syndrome and thymoma].
Fukuda A; Sato Y; Iwatsubo S; Komatsu H; Nishiura R; Fukudome K; Yamada K; Hara S; Fujimoto S; Kitamura K
Nihon Jinzo Gakkai Shi; 2009; 51(2):130-7. PubMed ID: 19378799
[TBL] [Abstract][Full Text] [Related]
13. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review.
Frassinetti Castelo Branco Camurça Fernandes P; Bezerra Da Silva G; De Sousa Barros FA; Costa Oliveira CM; Kubrusly M; Evangelista JB
J Nephrol; 2005; 18(6):711-20. PubMed ID: 16358229
[TBL] [Abstract][Full Text] [Related]
14. Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome.
Eguchi A; Takei T; Yoshida T; Tsuchiya K; Nitta K
Nephrol Dial Transplant; 2010 Jan; 25(1):124-9. PubMed ID: 19740915
[TBL] [Abstract][Full Text] [Related]
15. Sera from patients with collapsing focal segmental glomerulosclerosis increase albumin permeability of isolated glomeruli.
McCarthy ET; Sharma M; Sharma R; Falk RJ; Jennette JC
J Lab Clin Med; 2004 Apr; 143(4):225-9. PubMed ID: 15085081
[TBL] [Abstract][Full Text] [Related]
16. Permeability factors in focal segmental glomerulosclerosis.
Savin VJ; McCarthy ET; Sharma M
Semin Nephrol; 2003 Mar; 23(2):147-60. PubMed ID: 12704575
[TBL] [Abstract][Full Text] [Related]
17. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.
McCarthy ET; Sharma M; Savin VJ
Clin J Am Soc Nephrol; 2010 Nov; 5(11):2115-21. PubMed ID: 20966123
[TBL] [Abstract][Full Text] [Related]
18. Minimal-change nephrotic syndrome associated with malignant mesothelioma.
Schroeter NJ; Rushing DA; Parker JP; Beltaos E
Arch Intern Med; 1986 Sep; 146(9):1834-6. PubMed ID: 3753125
[TBL] [Abstract][Full Text] [Related]
19. Humoral permeability factors in the nephrotic syndrome: a compendium and prospectus.
Musante L; Candiano G; Zennaro C; Bruschi M; Carraro M; Artero M; Ghiggeri GM
J Nephrol; 2001; 14 Suppl 4():S48-50. PubMed ID: 11798145
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin s disease with nephrotic syndrome as a complication of ulcerative colitis: case report.
Basić-Jukić N; Radman I; Roncević T; Jakić-Razumović J
Croat Med J; 2002 Oct; 43(5):573-5. PubMed ID: 12402399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
